PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

General provisions related to the pharmaceutical industry including prescription drug affordability and access, intellectual property, privacy, 340B drug discount program policy, and clinical trial diversity issues; FY2025 Appropriations Process monitoring; Implementation of H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169); Issues related to the role of pharmacy benefit managers in drug pricing including H.R.6283, DRUG Act.

Issues related to Medicare Part D access and drug pricing negotiation, compulsory licensing policy, and insulin policy.

Issues related to WTO TRIPS. Intellectual property issues.

General provisions related to the pharmaceutical industry including prescription drug affordability and access, intellectual property, privacy, 340B drug discount program policy, and clinical trial diversity issues; FY2025 Appropriations Process; Implementation of H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169); Issues related to the role of pharmacy benefit managers in drug pricing including H.R.6283, DRUG Act.

General provisions related to the pharmaceutical industry including prescription drug affordability and access, intellectual property, privacy, 340B drug discount program policy, and clinical trial diversity issues; FY2024 Appropriations Process; Implementation of H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169); Issues related to the role of pharmacy benefit managers in drug pricing including H.R.6283, DRUG Act.